Company Search:
Advanced Search
Sponsored Links
Endocyte, Inc. Company Snapshot
Endocyte, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Endocyte with three other companies in this sector in the United States: Americann Inc (2016 sales of $60,000.00 ), Clovis Oncology Inc ($78,000.00 of which 100% was Anti Cancer Medicines), and Cara Therapeutics Inc ($86,000.00 of which 100% was Pharmaceutical).

Sales Analysis. During the year ended December of 2016, sales at Endocyte were $70,000.00 . This is a very small increase of 0.0% versus 2015, when the company's sales were $70,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Endocyte, Inc.
  Stock Performance Chart for Endocyte, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 4.06
(Figures in U.S. Dollars)
1 Week -6.5%   13 Weeks -7.9%  
4 Weeks -6.5%   52 Weeks 58.0%  
Endocyte, Inc. Key Data:
  Ticker: ECYT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 70,000
(Year Ending Jan 2017).
Employees: 76
  Currency: U.S. Dollars Market Cap: 172,052,739
  Fiscal Yr Ends: December Shares Outstanding: 42,377,522
  Share Type: Common Closely Held Shares: 3,712,484
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.